Zydus Lifesciences has enclosed disclosures in prescribed Form ‘C’ under Regulation 7(2) of SEBI (Prohibition of Insider Trading) Regulations, 2015, received from Promoters, Promoters Group, Directors and their immediate relatives with respect to acceptance of Equity Shares of Re 1 each of the Company tendered under buyback through tender offer on proportionate basis.
The above information is a part of company’s filings submitted to BSE.